Post by
forhandlaren on Jun 14, 2022 2:58pm
The prc PARTNERS interview
prc PARTNERS is a shareholder as everyone else? Or maybe not!
I think they were given information pre-deal based on:
- the interview is very polished - I like it, but very hard to accomplish in one day
- getting hold of three key management resources during the ongoing conference?
- the reference to share price close Friday June 10th on investment highlights
That raises the question of they bought shares based on in-the-know pre-deal?!
It also suggest that the close relationship indicates that the numbers published by prc PARTNERS pre- and post-deal are related to the real world. Could of course be debated.Was it $20M upfront?
Nevertheless, there are interesting breadcrumbs:
- AbbVie seems to already have started the product development which is very positive of course
- animal health deal expected to be closed this autumn
- upfront is invested in accelerated development
- $40M royalty equals about 1.86 CAD per share at P/E 10 and 275M shares - does prc PARTNERS speculate or are they in-the-know? Doesn't really matter as the numbers seems realistic anyway.
Sirona Biochem states on Twitter that "There are many more news to come in the next days" - does it refer to the post-deal interview or something else? I would be very surprised if there's more to bring to the market this week given the prc PARTNERS interview that covers a lot.
Comment by
forhandlaren on Jun 15, 2022 2:46am
prc PARTNERS launched a new web site more or less at the same time as Sirona launched theirs. Old posts were removed in the process. Thanks for the article, good read. Seems like an upfront between 2M and 20M is reasonable (USD, multiply with 1.28 for CAD). Since milestones are involved, the upfront might be in the lower span.
Comment by
noclue80 on Jun 15, 2022 3:35am
TFC-1067 0,4% study release? finally?!
Comment by
jimmyhorizon on Jun 15, 2022 7:10am
no the question is not whether someone bought in the know before the deal, but sold in the know after the hype.